235 related articles for article (PubMed ID: 30767755)
21. Drug targeting to cancer by nanoparticles surface functionalized with special biomolecules.
Holgado MA; Martin-Banderas L; Alvarez-Fuentes J; Fernandez-Arevalo M; Arias JL
Curr Med Chem; 2012; 19(19):3188-95. PubMed ID: 22612702
[TBL] [Abstract][Full Text] [Related]
22. Advances in Functionalized Mesoporous Silica Nanoparticles for Tumor Targeted Drug Delivery and Theranostics.
Zhang W; Liu M; Liu A; Zhai G
Curr Pharm Des; 2017; 23(23):3367-3382. PubMed ID: 27784244
[TBL] [Abstract][Full Text] [Related]
23. The upcoming field of theranostic nanomedicine: an overview.
Prabhu P; Patravale V
J Biomed Nanotechnol; 2012 Dec; 8(6):859-82. PubMed ID: 23029995
[TBL] [Abstract][Full Text] [Related]
24. Role of Nanotechnology in Delivery of Protein and Peptide Drugs.
Patil S; Vhora I; Amrutiya J; Lalani R; Misra A
Curr Pharm Des; 2015; 21(29):4155-73. PubMed ID: 26323432
[TBL] [Abstract][Full Text] [Related]
25. Emerging Trends and Potential Prospects in Vaginal Drug Delivery.
Mahant S; Sharma AK; Gandhi H; Wadhwa R; Dua K; Kapoor DN
Curr Drug Deliv; 2023; 20(6):730-751. PubMed ID: 35422213
[TBL] [Abstract][Full Text] [Related]
26. Overcoming barriers by local drug delivery with liposomes.
Antimisiaris SG; Marazioti A; Kannavou M; Natsaridis E; Gkartziou F; Kogkos G; Mourtas S
Adv Drug Deliv Rev; 2021 Jul; 174():53-86. PubMed ID: 33539852
[TBL] [Abstract][Full Text] [Related]
27. Nanomedicine for Cystic Fibrosis.
Ong V; Mei V; Cao L; Lee K; Chung EJ
SLAS Technol; 2019 Apr; 24(2):169-180. PubMed ID: 30707858
[TBL] [Abstract][Full Text] [Related]
28. Improved vaginal retention and enhanced antifungal activity of miconazole microsponges gel: Formulation development and in vivo therapeutic efficacy in rats.
Salah S; Awad GEA; Makhlouf AIA
Eur J Pharm Sci; 2018 Mar; 114():255-266. PubMed ID: 29288706
[TBL] [Abstract][Full Text] [Related]
29. Micro- and nanoparticles--medical applications.
Jătariu A; Peptu C; Popa M; Indrei A
Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):1160-9. PubMed ID: 20191893
[TBL] [Abstract][Full Text] [Related]
30. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
31. The emerging applications of magnetic nanovectors in nanomedicine.
Seeney CE
Pharm Pat Anal; 2015; 4(4):285-304. PubMed ID: 26174567
[TBL] [Abstract][Full Text] [Related]
32. Recent trends of nanomedicinal approaches in clinics.
Dilnawaz F; Acharya S; Sahoo SK
Int J Pharm; 2018 Mar; 538(1-2):263-278. PubMed ID: 29339248
[TBL] [Abstract][Full Text] [Related]
33. Nanoparticle Based Treatment for Cardiovascular Diseases.
Gupta P; Garcia E; Sarkar A; Kapoor S; Rafiq K; Chand HS; Jayant RD
Cardiovasc Hematol Disord Drug Targets; 2019; 19(1):33-44. PubMed ID: 29737265
[TBL] [Abstract][Full Text] [Related]
34. Combined use of nanocarriers and physical methods for percutaneous penetration enhancement.
Dragicevic N; Maibach H
Adv Drug Deliv Rev; 2018 Mar; 127():58-84. PubMed ID: 29425769
[TBL] [Abstract][Full Text] [Related]
35. Nanoparticles for brain-specific drug and genetic material delivery, imaging and diagnosis.
Posadas I; Monteagudo S; Ceña V
Nanomedicine (Lond); 2016 Apr; 11(7):833-49. PubMed ID: 26980585
[TBL] [Abstract][Full Text] [Related]
36. Nanotherapeutics for the Treatment of Cancer and Arthritis.
Patel P; Meghani N; Kansara K; Kumar A
Curr Drug Metab; 2019; 20(6):430-445. PubMed ID: 30479211
[TBL] [Abstract][Full Text] [Related]
37. Nanocarriers for oral drug delivery.
Zhang L; Wang S; Zhang M; Sun J
J Drug Target; 2013 Jul; 21(6):515-27. PubMed ID: 23621127
[TBL] [Abstract][Full Text] [Related]
38. Biopharmaceutical parameters to consider in order to alter the fate of nanocarriers after oral delivery.
Roger E; Lagarce F; Garcion E; Benoit JP
Nanomedicine (Lond); 2010 Feb; 5(2):287-306. PubMed ID: 20148639
[TBL] [Abstract][Full Text] [Related]
39. Preparation of end-capped pH-sensitive mesoporous silica nanocarriers for on-demand drug delivery.
Moreira AF; Gaspar VM; Costa EC; de Melo-Diogo D; Machado P; Paquete CM; Correia IJ
Eur J Pharm Biopharm; 2014 Nov; 88(3):1012-25. PubMed ID: 25229810
[TBL] [Abstract][Full Text] [Related]
40. Progresses in Nano-Enabled Platforms for the Treatment of Vaginal Disorders.
Patel R; Yadav BK; Patel G
Recent Pat Nanotechnol; 2023; 17(3):208-227. PubMed ID: 35762539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
